Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk's OzempicMarket Watch • 12/04/23
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffsCNBC • 11/30/23
Novo Nordisk Sues Two Florida Pharmacies For Allegedly Selling Impure Weight-Loss DrugsForbes • 11/30/23
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?The Motley Fool • 11/29/23
New Highs: Novo Nordisk, PGT Innovations Among Best Stocks To Buy NowInvestors Business Daily • 11/24/23
Ozempic maker plans manufacturing blitz as market for the drug is expected to top $100 billion in 2030Business Insider • 11/23/23
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, FranceGlobeNewsWire • 11/23/23